News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
03-Dec-2001 - On World AIDS Day 2001, Boehringer Ingelheim reports on the successful progress of its initiatives in the battle against HIV/AIDS in the developing world. Since the delivery of drug supplies to Congo (Brazzaville) and Senegal as the first countries in the Boehringer Ingelheim VIRAMUNE® ...
29-Nov-2001 - Boehringer Ingelheim International GmbH and ImmunoGen, Inc. (Nasdaq: IMGN) today announced a collaboration to develop a new product combining ImmunoGen’s maytansinoid Tumor-Activated Prodrug (TAP) technology with a Boehringer Ingelheim antibody. Under the terms of the agreement, Boehringer ...
18-Oct-2001 - Boehringer Ingelheim announced today that it has received an approval from the Medicinal Evaluation Board in Den Haag, Netherlands for its COPD drug Spiriva® (tiotropium). Spiriva’s approved indication is for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease - ...
27-Apr-2001 - Boehringer Ingelheim ended the financial year 2000 with a marked increase in both turnover and net income. As the company announced at its annual results press conference today, net sales rose by 22 per cent to EUR 6.2 billion. Operating income also increased by 22 per cent to EUR 800 ...
12-Apr-2001 - Boehringer Ingelheim and Pfizer Inc announced today that they have entered into a long-term worldwide agreement to jointly market SPIRIVA® (tiotropium), a novel once-a-day inhaled treatment for Chronic Obstructive Pulmonary Disease (COPD), which includes chronic bronchitis and emphysema. ...
01-Feb-2001 - Boehringer Ingelheim has established a pioneering Virtual Research Institute of Aging in the Pan-Pacific region. The institute, headed by Dr Haruo Sugano, the Honorary Director of the Cancer Institute in Japan, creates a virtual network of scientists selected from the Pan-Pacific area. This ...
26-Jan-2001 - Boehringer Ingelheim officially replied to letters from Médecins sans Frontières (MSF) /(Doctors without Borders) sent to many of the Boehringer Ingelheim operating units worldwide demanding that the price of VIRAMUNE® should be reduced by 95 per cent for developing countries or that ...
29-Dec-2000 - Boehringer Ingelheim Vetmedica GmbH (BIV) has filed world-wide patents on a procedure to test bovine spongiform encephalopathy (BSE) in living animals. Contrary to the tests which are actually used based on brain histopathology, which can only be undertaken after the animal has been ...
19-Dec-2000 - Boehringer Ingelheim Vetmedica GmbH (BIV) has filed world-wide patents on a procedure to test bovine spongiform encephalopathy (BSE) in living animals. Contrary to the tests which are actually used based on ...
01-Dec-2000 - The anti-HIV drug VIRAMUNE® (nevirapine) was given by Boehringer Ingelheim free of charge to representatives of the Republic of Congo (Congo Brazzaville) for the prevention of mother-to-child transmission ...
© 1997-2024 LUMITOS AG, All rights reserved